16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases
Key Takeaways
- Under the 2017 AAP/EFP World Workshop Classification, Peri-Implant Mucositis is defined as plaque-induced soft tissue inflammation (BOP/suppuration) without bone loss beyond initial remodeling, whereas Peri-Implantitis involves mucosal inflammation combined with progressive crestal bone loss.
- Diagnostic criteria for Peri-Implantitis in the absence of baseline data require Bleeding on Probing (BOP) and/or suppuration, probing depths ≥6.0 mm, and crestal bone levels ≥3.0 mm apical to the intra-mucosal portion of the implant.
- Major modifiable and non-modifiable risk factors include a history of severe periodontitis (odds ratio 2–5x), tobacco smoking, uncontrolled diabetes, lack of keratinized mucosa (<2.0 mm), and subgingival entrapment of residual restorative cement.
- Peri-Implant Mucositis is fully reversible with non-surgical mechanical debridement, glycine/erythritol air-polishing, and chemical plaque control; conversely, non-surgical therapy alone shows low predictability in resolving Peri-Implantitis.
- Surgical management of Peri-Implantitis incorporates open flap debridement, implant surface decontamination (titanium brushes, citric acid, air-polishing), and either resective surgery with implantoplasty or regenerative Guided Bone Regeneration (GBR), guided by the Cumulative Interceptive Supportive Therapy (CIST) protocol.
16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases
Peri-implant diseases represent plaque-associated inflammatory conditions occurring in the tissues surrounding dental implants. Defined globally by the 2017 AAP/EFP World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions and endorsed by the Australian Society of Periodontology (ASP) and Dental Board of Australia (DBA), peri-implant conditions range from reversible soft tissue inflammation to progressive, destructive bone loss. For candidates taking the ADC Written Examination, a thorough understanding of the diagnostic definitions, risk factor profiles, non-surgical interceptive protocols, surgical decontamination techniques, and explantation criteria is essential.
1. 2017 AAP/EFP Classification & Diagnostic Criteria
The 2017 World Workshop established standardized, evidence-based diagnostic criteria distinguishing peri-implant health, peri-implant mucositis, and peri-implantitis.
| Classification | Visual Inflammation | Bleeding on Probing (BOP) / Suppuration | Probing Depth (PD) | Radiographic Crestal Bone Levels |
|---|---|---|---|---|
| Peri-Implant Health | Absence of erythema, edema, or swelling. | Absence of BOP and suppuration. | Stable baseline PDs (typically ≤3–4 mm). | Absence of bone loss beyond physiological remodeling (≤1.5–2.0 mm post-loading). |
| Peri-Implant Mucositis | Presence of erythema, edema, and mucosal swelling. | Presence of BOP and/or suppuration. | Increased PD compared to baseline due to swelling. | Absence of progressive bone loss beyond initial physiological remodeling. |
| Peri-Implantitis | Visual mucosal inflammation and swelling. | Presence of BOP and/or suppuration upon probing. | Increased PD (typically ≥6.0 mm) compared to baseline. | Progressive crestal bone loss extending beyond physiological remodeling. |
Diagnostic Cutoffs when Baseline Radiographs / Probing Depths are ABSENT:
When previous clinical records or baseline radiographs are unavailable, the 2017 AAP/EFP classification mandates diagnosing Peri-Implantitis based on the following triad:
- Presence of Bleeding on Probing (BOP) and/or suppuration.
- Probing Depths ≥6.0 mm.
- Radiographic bone levels ≥3.0 mm apical to the most coronal portion of the intra-mucosal part of the implant.
2. Etiology & Risk Factors / Indicators
Peri-implantitis is an infectious disease driven by polymicrobial biofilm dysbiosis, characterized by a shift toward anaerobic Gram-negative periodontopathogens (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum). Several local and systemic risk factors significantly increase patient susceptibility.
+-----------------------------------------------------------------------------------------+
| RISK FACTORS & INDICATORS FOR PERI-IMPLANTITIS |
+-----------------------------------------------------------------------------------------+
| Patient-Related | History of severe periodontitis (OR 2-5x), Smoking, Uncontrolled Diabetes |
| Local / Tissue | Lack of Keratinized Mucosa (<2.0 mm), Poor oral hygiene / compliance |
| Iatrogenic | Subgingival RESIDUAL CEMENT entrapment, Implant malposition |
+-----------------------------------------------------------------------------------------+
- History of Periodontitis: The strongest patient-level risk factor. Untreated or poorly managed periodontitis provides a reservoir of pathogenic bacteria that cross-colonize peri-implant sites.
- Subgingival Excess Restorative Cement (Iatrogenic): Retained subgingival cement following cementation of implant crowns creates a rough, porous substrate for heavy bacterial colonization. This frequently triggers acute, rapid suppurative breakdown and severe localized bone loss.
- Lack of Keratinized Mucosa (<2.0 mm): A band of keratinized tissue <2.0 mm around transmucosal abutments increases patient discomfort during brushing, plaque accumulation, mucosal recession, and tissue inflammation.
- Implant Malposition & Uncleanable Prosthetic Contours: Implants placed too close together (<3.0 mm) or crowns featuring concave, non-cleansable emergence profiles prevent effective mechanical plaque control by the patient.
3. Non-Surgical Management Protocols
Non-surgical therapy is the mandatory first-line treatment for peri-implant mucositis and serves as the initial phase of peri-implantitis control.
A. Peri-Implant Mucositis Treatment (Fully Reversible)
- Mechanical Debridement: Complete removal of biofilm and calculus using pure titanium scalers, carbon-fiber curettes, or subgingival glycine/erythritol air-polishing.
- Removal of Iatrogenic Triggers: Elimination of overhanging crown margins and complete removal of subgingival residual cement.
- Antiseptic Rinses: 0.12% Chlorhexidine gluconate mouthrinse twice daily for 2 to 3 weeks.
- Prosthetic Modification: Recontouring crown contours if they impede interdental brushing.
- Prognosis: High predictability; full resolution of inflammation and return to health.
B. Non-Surgical Treatment of Peri-Implantitis (Limited Predictability)
- While non-surgical debridement reduces soft tissue inflammation, it rarely achieves complete disease resolution or re-osseointegration in deeper peri-implantitis pockets (≥6.0 mm).
- Adjunctive Antimicrobials: Controlled-release local antimicrobials (e.g., Minocycline microspheres or Doxycycline hyclate gel) placed into deep pockets provide modest short-term probing depth reductions.
- Systemic Antibiotics: Routine systemic antibiotics during non-surgical therapy are not recommended due to limited efficacy and antimicrobial resistance concerns.
4. Surgical Interventions for Peri-Implantitis
When non-surgical therapy fails to eliminate deep pockets (≥6.0 mm), suppuration, and active BOP after 6 to 12 weeks, surgical intervention is indicated.
+-----------------------------------------------------------------------------------------+
| SURGICAL MANAGEMENT OF PERI-IMPLANTITIS |
+-----------------------------------------------------------------------------------------+
| Step 1: Open Flap Debridement (OFD) | Full-thickness mucoperiosteal flap reflection |
| Step 2: Surface Decontamination | Titanium brushes, Citric acid 24%, Air-polishing |
| Step 3A: Resective + Implantoplasty | Smoothing exposed threads (Non-esthetic zones) |
| Step 3B: Regenerative (GBR) | Bone graft + Barrier membrane (3-wall defects) |
+-----------------------------------------------------------------------------------------+
A. Step 1: Flap Reflection & Granulation Tissue Removal
- Full-thickness mucoperiosteal flaps are reflected buccally and lingually under local anesthesia.
- Inflammatory granulation tissue filling the intra-bony defect is completely curetted using titanium scalers.
B. Step 2: Implant Surface Decontamination (Critical Phase)
Decontamination of the contaminated, micro-rough titanium surface is necessary to render the surface biocompatible.
- Mechanical Decontamination: Rotary titanium brushes, subgingival glycine/erythritol air-polishing, or Er:YAG laser ablation.
- Chemical Decontamination: Application of 24% Citric Acid for 1 minute, 3% Hydrogen Peroxide, or Chlorhexidine 0.2% gel, followed by copious sterile saline irrigation.
C. Step 3: Selection of Surgical Modality
- Resective Surgery & Implantoplasty:
- Indications: Suprabony defects, 1-wall or 2-wall shallow bone defects, and non-esthetic areas (posterior mandible).
- Procedure: Apical positioning of the soft tissue flap combined with Implantoplasty—using diamond and carbide burs to smooth away the rough exposed titanium threads, leaving a polished surface that inhibits re-colonization by bacterial biofilm.
- Regenerative Surgery (Guided Bone Regeneration - GBR):
- Indications: Self-containing, deep intra-bony defects (3-wall or circumferential defects) in esthetic zones.
- Procedure: Filling the decontaminated defect with particulate bone graft (autogenous bone combined with xenograft/bovine bone mineral) and covering with a resorbable collagen barrier membrane to achieve re-osseointegration.
5. Cumulative Interceptive Supportive Therapy (CIST) & Explantation
The CIST Protocol offers a structured, step-wise clinical treatment matrix based on probing depth, bleeding, and bone loss severity.
| CIST Stage | Clinical Findings | Required Interceptive Treatment |
|---|---|---|
| Stage A | Probing Depth 3–4 mm, Bleeding on Probing (+) | Mechanical Debridement: Oral hygiene instruction, polishing, air-polishing. |
| Stage B | Probing Depth 4–5 mm, Bleeding on Probing (+) | Antiseptic Therapy: Stage A + Chlorhexidine 0.12% irrigation/rinse for 3 weeks. |
| Stage C | Probing Depth >5 mm, BOP (+), Bone Loss 2–4 mm | Antimicrobial Therapy: Stage A + B + Local controlled-release antibiotics. |
| Stage D | Probing Depth >5 mm, BOP (+), Bone Loss >4 mm | Surgical Therapy: Stage A + B + C + Open flap debridement, surface decontamination, and Resective/Regenerative surgery. |
Indications for Implant Explantation (Removal)
Implant retention is not always viable. Explantation is mandatory under the following conditions:
- Clinical Fixture Mobility: Pathognomonic for total loss of osseointegration.
- Extreme Bone Loss (>50% to 70% of implant length): Accompanied by refractory suppuration despite surgical intervention.
- Severe Implant Malposition: Renders the implant unrestorable or un-cleansable.
- Technique: Explantation should utilize reverse-torque extraction kits or ultra-thin trephine burs to preserve host bone for future site reconstruction.
According to the 2017 AAP/EFP World Workshop Classification, what specific combination of clinical findings establishes a diagnosis of Peri-Implantitis in a patient where baseline probing records and initial post-loading radiographs are unavailable?
What is the critical clinical distinction between Peri-Implant Mucositis and Peri-Implantitis regarding disease progression and treatment outcome?
During open flap resective surgery for peri-implantitis in a non-esthetic posterior mandibular site, the clinician performs an implantoplasty. What is the primary objective of performing implantoplasty during this procedure?
A patient presenting with a single-implant restoration exhibits deep probing depths of 7 mm, active suppuration, and radiographic bone loss of 3.5 mm (Stage C/D CIST). Non-surgical therapy has failed. The defect is a narrow, self-containing 3-wall intra-bony defect in the esthetic maxilla. Which surgical intervention is indicated?
You've completed this section
Continue exploring other exams